| Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer V Esposito, A Baldi, A De Luca, AM Groger, M Loda, GG Giordano, ... Cancer Research 57 (16), 3381-3385, 1997 | 565 | 1997 |
| p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107 PP Claudio, CM Howard, A Baldi, A De Luca, Y Fu, G Condorelli, Y Sun, ... Cancer research 54 (21), 5556-5560, 1994 | 267 | 1994 |
| PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro X Grana, A De Luca, N Sang, Y Fu, PP Claudio, J Rosenblatt, DO Morgan, ... Proceedings of the National Academy of Sciences 91 (9), 3834-3838, 1994 | 255 | 1994 |
| Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases A De Luca, M Santra, A Baldi, A Giordano, RV Iozzo Journal of Biological Chemistry 271 (31), 18961-18965, 1996 | 247 | 1996 |
| The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas A De Luca, A Baldi, V Esposito, CM Howard, L Bagella, P Rizzo, M Caputi, ... Nature medicine 3 (8), 913-916, 1997 | 231 | 1997 |
| Modelling of historical masonry structures: comparison of different approaches through a case study A Giordano, E Mele, A De Luca Engineering Structures 24 (8), 1057-1069, 2002 | 220 | 2002 |
| The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells A Baldi, A De Luca, M Morini, T Battista, A Felsani, F Baldi, C Catricala, ... Oncogene 21 (43), 6684-6688, 2002 | 203 | 2002 |
| Functional analysis of pRb2/p130 interaction with cyclins PP Claudio, A De Luca, CM Howard, A Baldi, EJ Firpo, A Koff, MG Paggi, ... Cancer Research 56 (9), 2003-2008, 1996 | 145 | 1996 |
| Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes A Nebbioso, F Manzo, M Miceli, M Conte, L Manente, A Baldi, A De Luca, ... EMBO reports 10 (7), 776-782, 2009 | 143 | 2009 |
| Prognostic value of immunohistochemical expression of p53, bax, Bcl‐2 and Bcl‐xL in resected non‐small‐cell lung cancers AM Groeger, V Esposito, A De Luca, R Cassandro, G Tonini, V Ambrogi, ... Histopathology 44 (1), 54-63, 2004 | 130 | 2004 |
| Behavior of full-scale glass fiber-reinforced polymer reinforced concrete columns under axial load A De Luca, F Matta, A Nanni ACI structural journal 107 (5), 589, 2010 | 127 | 2010 |
| Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer. A Baldi, V Esposito, A De Luca, Y Fu, I Meoli, GG Giordano, M Caputi, ... Clinical Cancer Research 3 (10), 1691-1697, 1997 | 122 | 1997 |
| Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest C Guillouf, X Grana, M Selvakumaran, A De Luca, A Giordano, B Hoffman, ... | 118 | 1995 |
| Distribution of the serine protease HtrA1 in normal human tissues A De Luca, M De Falco, A Severino, M Campioni, D Santini, F Baldi, ... Journal of Histochemistry & Cytochemistry 51 (10), 1279-1284, 2003 | 114 | 2003 |
| The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter P Stiegler, A De Luca, L Bagella, A Giordano Cancer research 58 (22), 5049-5052, 1998 | 113 | 1998 |
| Structural evaluation of full-scale FRP-confined reinforced concrete columns A De Luca, F Nardone, F Matta, A Nanni, GP Lignola, A Prota Journal of Composites for Construction 15 (1), 112-123, 2011 | 110 | 2011 |
| Apelin expression in normal human tissues M De Falco, L De Luca, N Onori, I Cavallotti, F Artigiano, V Esposito, ... IN VIVO-ATHENS- 16 (5), 333-336, 2002 | 106 | 2002 |
| Activation of MyoD-dependent transcription by cdk9/cyclin T2 C Simone, P Stiegler, L Bagella, B Pucci, C Bellan, G De Falco, ... Oncogene 21 (26), 4137-4148, 2002 | 105 | 2002 |
| Reinforced concrete with FRP bars: Mechanics and design A Nanni, A De Luca, HJ Zadeh CRC Press, 2014 | 104 | 2014 |
| Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin … O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ... The lancet Diabetes & endocrinology 5 (11), 887-897, 2017 | 98 | 2017 |
